Daily news and information for physicians in a range of specialties and practice settings.
FDA Votes in Favor of Romosozumab Approval for Osteoporosis
The FDA Bone, Reproductive, and Urologic Drugs Advisory Committee voted in favor of approving romosozumab for the treatment of postmenopausal women with osteoporosis at high risk for fracture.
A Multi-Marker Approach to Identify Coronary Artery Disease
Coronary artery disease remains the top killer of Americans—these tools may help identify people who are still at risk.
Early Gene Therapy Trials for Retina Disorder Yield Promise
University of Pennsylvania investigators conducted an interim analysis of a year-long study on intraocular injections of a mutation-specific gene therapy when one patient showed dramatic early improvements.
Studies Highlight HIV Disparities in Transgender Community
A new review shows transgender women face higher HIV rates than transgender men, but also finds a relative lack of data about transmen.
Treating Vitamin D Deficiencies Could Curb COPD Exacerbation
Meta-analysis of other randomized controlled trials have shown that vitamin D supplementation reduces the risk of acute respiratory infections and exacerbations of asthma.
Ocrelizumab Shows Superiority to or Comparability with Other Multiple Sclerosis Treatments
Ocrelizumab demonstrated superiority to or comparability with 14 other disease-modifying therapies currently approved by the European Medicines Agency.
Actelion Receives CRL for Macitentan CTEPH Indication
The FDA has responded to the Janssen Pharmaceutical company's sNDA with a request for more data.
FDA Approves Generic Vigabatrin Tablets
This is the first generic approval of the tablet form of vigabatrin, which is indicated for treating focal seizures in patients with epilepsy.
FDA Approves Scalpel-Free Parkinson Treatment
The FDA has approved a scalpel-free method for the treatment of patients with Parkinson disease who experience tremors and are medication-resistant.
FDA Fast Tracks Oral Antibiotic for
Currently in phase 1 testing, ACX-362E is being developed as a narrow spectrum antibiotic for the treatment of
Next Page >>
FDA Approves Tdap Booster Vaccine
What Should I Do With This Abnormal ALT?
Top 10 Painkillers in the US
Pregnancy, Obesity & Immunosuppression Among High-Risk Factors for Flu Complications in Updated Guidelines
Ongoing Research for CMV Management in HSCT Patients
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
MD Magazine Resources
Terms & Conditions
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.